Tuesday - March 24, 2026

Myelofibrosis Drug Development Surges: 40+ Pipeline Candidates Across 35+ Companies Reshape Treatment Landscape, analyses DelveInsight

Myelofibrosis Clinical trial Leading Myelofibrosis Companies working in the space include Incyte, Keros Therapeutics, Karyopharm Therapeutics, Celgene, PharmaEssentia, Novartis, SecuraBio, Pharmaxis, AstraZeneca, Cellenkos, Jacobio Pharmaceuticals, Geron Corporation, AbbVie, Sierra Oncology, Galecto Biotech, Kartos Therapeutics, Menarini Group, Telios Pharma, MorphoSys, Roche, … Continue reading

Global Bispecific Antibody Pipeline Expands Rapidly with 250+ Therapies Across 180+ Companies | DelveInsight Analysis

Bispecific Antibody Clinical Trials Leading Bispecific Antibody Companies working in the space include I-MAB Biopharma, Bristol Myers Squibb, AstraZeneca, BioNTech, Genmab, Compass Therapeutics, Innovent, Regeneron Pharmaceuticals, Aurigene Oncology, Curis, Akeso, Summit Therapeutics, Roche, Merus, Adimab, Creative Biolabs, Amgen, Zymeworks, Xencor, … Continue reading

Pancreatic Ductal Adenocarcinoma Pipeline Gains Significant Traction with 80+ Companies Advancing Novel Therapies | DelveInsight

Pancreatic Ductal Adenocarcinoma Pipeline Pancreatic Ductal Adenocarcinoma companies include Cardiff Oncology, XOMA, Alphamab, Cantargia, RenovoRx, Syntrix Biosystems, Eucure Biopharma, Panbela Therapeutics, Jeil Pharmaceutical, Elicio Therapeutics, Cend Therapeutics, SignalChem Lifesciences, Bristol Myers Squibb, AstraZeneca, REVOLUTION Medicines, Arcus Biosciences, ZielBio, Surface Oncology, … Continue reading

Osteoarthritis Pipeline Witnesses Strong Expansion with 100+ Companies Advancing 110+ Innovative Therapies | DelveInsight

Osteoarthritis Pipeline Leading Osteoarthritis companies include Biosplice Therapeutics, Cynata Therapeutics, Regeneron Pharmaceuticals, LG Chem, Bioventus, Asahi Kasei Pharma, Ampio Pharmaceuticals, and several other innovators actively contributing to Osteoarthritis drug development. DelveInsight’s latest report, “Osteoarthritis Pipeline Insights 2026” offers a comprehensive … Continue reading

Ocular Hypertension Pipeline Demonstrates Strong Momentum with 50+ Companies Advancing 75+ Therapies | DelveInsight

Ocular Hypertension Pipeline Ocular Hypertension companies include Santen Pharmaceutical, Nicox Ophthalmics, Allysta Pharmaceuticals, Qlaris Bio, Ripple Therapeutics, Laboratoires Théa, Ocular Therapeutix, Otsuka Beijing Research Institute, Alcon Research, AbbVie, Glaukos Corporation, MediPrint Ophthalmics, and Ocuphire Pharma, among others. DelveInsight’s latest report, … Continue reading

Artificial Intelligence in Diagnostics Market Set for Rapid Expansion at 22.31% CAGR Through 2032, According to DelveInsight

Artificial Intelligence in Diagnostics Market Artificial Intelligence in Diagnostics companies are Aidoc, Owkin, Siemens Healthineers, PathAI, Ibex, Imagen Technologies, Aiforia, RADLogics, Terarecon, Prenosis, Google LLC, GE HealthCare, DreaMed, Riverain Technologies, and others. The global Artificial Intelligence (AI) in Diagnostics market … Continue reading

Nuclear Medicine (Radiopharmaceuticals) Market Set for Strong Growth at 9.50% CAGR Through 2034: DelveInsight | Lantheus, GE Healthcare, Novartis, Sotera Health and Others

Nuclear Medicine (Radiopharmaceuticals) Market Insights Key companies operating in the nuclear medicine (radiopharmaceuticals) market include Lantheus, Cardinal Health, GE Healthcare, Curium Pharma, Pharmalogic Holdings Corp., Novartis, Cambridge Isotope Laboratories Inc., Sotera Health LLC, Bracco Imaging SpA, Jubilant Pharma Limited, NECSA … Continue reading

Hip Reconstruction/Replacement Devices Market Set for Steady Growth at 5.51% CAGR Through 2034: DelveInsight | Zimmer Biomet, Stryker Corporation,Smith & Nephew and Others

Hip Reconstruction/Replacement Devices Market Insights The global hip replacement devices market is poised for robust and sustained expansion, driven by the rising prevalence of bone-related disorders and continuous technological advancements by global players including, Exactech, Inc., Johnson & Johnson Services, … Continue reading

Metastatic Renal Cell Carcinoma Treatment Pipeline Shows Strong Momentum as 40+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Metastatic Renal Cell Carcinoma Pipeline Insights 2026” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in Metastatic Renal Cell Carcinoma pipeline landscape. It covers the Metastatic Renal Cell Carcinoma pipeline drug profiles, including clinical and nonclinical … Continue reading